Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
Open-market buys, last 90 days
$29,501
in 3 filings
Open-market sales, last 90 days
$27,505
in 1 filing, $28K under 10b5-1 plans

Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 39 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-03 Scimeca Dario General Counsel and Secretary Option exercise · Restricted Stock Units −27,558 55,101
2023-03-03 List Alan Chief Medical Officer Option exercise +29,453 47,713
2023-03-03 List Alan Chief Medical Officer Option exercise · Restricted Stock Units +29,453 58,890
2023-03-03 SMITH J. JEFFERSON Chief Research Officer Option exercise +15,576 1,930,207
2023-03-03 SMITH J. JEFFERSON Chief Research Officer Option exercise · Restricted Stock Units −15,576 31,144
2023-03-03 Kelly John Alexander Chief Financial Officer Option exercise +51,071 225,614
2023-03-03 Kelly John Alexander Chief Financial Officer Option exercise · Restricted Stock Units −51,071 102,114
2023-03-03 Barton Shane VP & Corporate Controller Option exercise +12,722 21,422
2023-03-03 Barton Shane VP & Corporate Controller Option exercise · Restricted Stock Units −12,722 25,439
2023-02-28 Scimeca Dario General Counsel and Secretary Grant or award +2,163 $0.95 $2K 34,677
2023-02-28 SMITH J. JEFFERSON Chief Research Officer Grant or award +12,157 $0.95 $12K 1,914,631
2023-02-28 Kelly John Alexander Chief Financial Officer Grant or award +11,605 $0.95 $11K 174,543
2023-01-20 SMITH J. JEFFERSON Chief Research Officer Grant or award · Restricted Stock Units +225,000 225,000
2023-01-20 Kelly John Alexander Chief Financial Officer Grant or award · Restricted Stock Units +350,000 350,000
2023-01-20 Barton Shane VP & Corporate Controller Grant or award · Restricted Stock Units +70,000 70,000
2023-01-20 Amoroso Michael President and CEO Grant or award · Restricted Stock Units +800,000 800,000
2023-01-20 List Alan Chief Medical Officer Grant or award · Restricted Stock Units +180,000 180,000
2023-01-20 Scimeca Dario General Counsel and Secretary Grant or award · Restricted Stock Units +178,000 178,000
2022-11-02 Scimeca Dario General Counsel and Secretary Grant or award · Restricted Stock Units +165,200 165,200
2022-11-02 Kelly John Alexander Chief Financial Officer Grant or award · Restricted Stock Units +324,500 324,500

Page 14 of 23 · 456 trades